R

Revvity Inc
NYSE:RVTY

Watchlist Manager
Revvity Inc
NYSE:RVTY
Watchlist
Price: 112.34 USD 0.06%
Market Cap: 13.7B USD
Have any thoughts about
Revvity Inc?
Write Note

Revvity Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Revvity Inc
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
R
Revvity Inc
NYSE:RVTY
Cost of Revenue
-$1.2B
CAGR 3-Years
17%
CAGR 5-Years
4%
CAGR 10-Years
0%
Thermo Fisher Scientific Inc
NYSE:TMO
Cost of Revenue
-$25.1B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-11%
Danaher Corp
NYSE:DHR
Cost of Revenue
-$8.6B
CAGR 3-Years
8%
CAGR 5-Years
-4%
CAGR 10-Years
0%
Mettler-Toledo International Inc
NYSE:MTD
Cost of Revenue
-$1.5B
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
Agilent Technologies Inc
NYSE:A
Cost of Revenue
-$3B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
IQVIA Holdings Inc
NYSE:IQV
Cost of Revenue
-$9.9B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-10%
No Stocks Found

Revvity Inc
Glance View

Market Cap
13.7B USD
Industry
Life Sciences Tools & Services
Economic Moat
None

In the fast-evolving landscape of life sciences and diagnostics, Revvity Inc. stands as a vital player, driving innovation and delivering critical solutions to a diverse array of sectors. Established with a focus on precision, Revvity leverages its expertise in diagnostics and scientific services to address pressing global health challenges. The company operates by providing advanced analytical instruments, reagents, and software, enabling researchers and healthcare providers to conduct intricate analyses with unmatched reliability. Their offerings are crucial in areas such as prenatal and neonatal screening, as well as infectious disease detection, where accuracy is of paramount importance. Revenue generation at Revvity hinges on a hybrid model that includes product sales, service contracts, and licensing. By supplying state-of-the-art laboratory equipment, along with complementary services and software, the company creates a comprehensive ecosystem for research and diagnostic testing. The breadth of their portfolio appeals to a varied clientele, from hospital labs to large research institutions, ensuring a steady and diversified income stream. Furthermore, their commitment to research and development fosters long-term partnerships and secures their place at the forefront of scientific advancement, making Revvity a linchpin in both the healthcare and scientific communities.

RVTY Intrinsic Value
106.53 USD
Overvaluation 5%
Intrinsic Value
Price
R

See Also

What is Revvity Inc's Cost of Revenue?
Cost of Revenue
-1.2B USD

Based on the financial report for Sep 29, 2024, Revvity Inc's Cost of Revenue amounts to -1.2B USD.

What is Revvity Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
0%

Over the last year, the Cost of Revenue growth was -1%. The average annual Cost of Revenue growth rates for Revvity Inc have been 17% over the past three years , 4% over the past five years .

Back to Top